Karyopharm Therapeutics reported $286.57M in Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acceleron Pharma XLRN:US $ 836.05M 39.74M
Amgen AMGN:US $ 59773M 2766M
Astrazeneca AZN:US $ 73641M 8715M
AstraZeneca AZN:LN 73641M 8715M
Avrobio Inc AVRO:US $ 238.1M 7.82M
Biocryst Pharmaceuticals BCRX:US $ 277.28M 7.15M
Bristol Myers Squibb BMY:US $ 110797M 1638M
Eli Lilly And LLY:US $ 47809M 970.7M
Enanta Pharmaceuticals ENTA:US $ 450.44M 17.33M
Epizyme EPZM:US $ 352.55M 54.16M
GlaxoSmithKline GSK:LN 77011M 1068M
Karyopharm Therapeutics KPTI:US $ 286.57M 11.66M
Macrogenics MGNX:US $ 425.91M 9.53M
Mirati Therapeutics MRTX:US $ 1355.7M 25.14M
Nektar Therapeutics NKTR:US $ 1371.35M 85.21M
Novartis NVS:US $ 124015M 2263M
Novartis NOVN:VX SF 124015M 2263M
Regeneron Pharmaceuticals REGN:US $ 21485.9M 3713.7M
Sangamo Biosciences SGMO:US $ 835.36M 41.73M
Takeda 4502:JP Y 12657234M 255059M
Tg Therapeutics TGTX:US $ 481.4M 67.3M
Ultragenyx Pharmaceutical RARE:US $ 1512.44M 85.32M
Xencor XNCR:US $ 695.6M 2.86M
YTE INCY:US $ 3904.62M 243.19M